Clinical Trials Directory

Trials / Unknown

UnknownNCT01731080

Arterial Wall Calcium Load in Pseudoxanthoma Elasticum

Arterial Wall Calcium Load and Preferential Sites in Pseudoxanthoma Elasticum Versus Type 2 Diabetes and Chronic Kidney Disease.

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Quantification and preferential sites of arterial wall calcification within the coronary and lower legs arteries will be comared between Pseudo-Xanthoma elasticum(PXE) atients and type 2 diabetics and Chronic Kidney disease.

Detailed description

In a previous work we have observed that patients suffering from PXE, a soft-tissue calcifying inherited autosomal disease, exhibited specific structural and functionnal features within the peripheral arteries. We now want to quantify and determine the preferential sites of the arterial wall calcification (Agatston score) between these patients compared to diabetics and patients with chronic renal insufficiency with mediacalcosis. All variables will be collected from a cohort of PXE monitored in our PXE Health and Care centre at the university hospital of Angers. Quantification of the arterial wall calcium load will be performed using helicoidal CT-scan. These variables will be compared to the same measurements performed in type 2 diabetic and chronic kidney disease patients paired by age and gender.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2012-11-21
Last updated
2012-11-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01731080. Inclusion in this directory is not an endorsement.